Kohchi; Yasunori

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kohchi; Yasunori.The latest application filed is for "orally available viridiofungin derivative possessing anti-hcv activity".

Company Profile

0.9.5

Kohchi; Yasunori - Kanagawa JP
Kohchi; Yasunori - Kamakura JP
Kohchi; Yasunori - Fujisawa JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Orally available viridiofungin derivative possessing anti-HCV activity Grant 9,266,853 - Kohchi , et al. February 23, 2	2016-02-23
Orally Available Viridiofungin Derivative Possessing Anti-hcv Activity App 20150210666 - Kohchi; Yasunori ; et al.	2015-07-30
5-substituted-2-phenylamino benzamides as MEK inhibitors Grant 8,575,391 - Isshiki , et al. November 5, 2	2013-11-05
4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors Grant 8,084,645 - Isshiki , et al. December 27, 2	2011-12-27
Process for production of 2,3,4-trifluoro-5-(iodo or bromo)-benzoic acid Grant 8,022,247 - Koyano , et al. September 20, 2	2011-09-20
5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors App 20100197676 - Isshiki; Yoshiaki ; et al.	2010-08-05
5-Substituted-2-phenylamino benzamides as MEK inhibitors Grant 7,745,663 - Isshiki , et al. June 29, 2	2010-06-29
5-Substituted-2-Phenylamino Benzamides as MEK Inhibitors App 20090233915 - Isshiki; Yoshiaki ; et al.	2009-09-17
Process for Production of 2,3,4-Trifluoro-5-(Iodo or Bromo)-Benzoic Acid App 20090209785 - Koyano; Hiroshi ; et al.	2009-08-20
4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors App 20070105859 - Isshiki; Yoshiaki ; et al.	2007-05-10
5'-deoxy-cytidine derivative administration to treat solid tumors Grant 6,211,166 - Hattori , et al. April 3, 2	2001-04-03
5'-deoxy-cytidine derivatives Grant 6,114,520 - Hattori , et al. September 5, 2	2000-09-05
5'deoxycytidine derivatives Grant 6,005,098 - Hattori , et al. December 21, 1	1999-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.